Bio-Techne TECH Cash Flow Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $51.05M+126% | $38.01M+8.9% | $38.19M+13.6% | —— | $22.59M-54.0% | ||
| $24.17M-12.3% | $24.71M-8.8% | $24.34M-13.5% | $27.11M-3.4% | $27.57M+1.0% | ||
| $10.5M-7.9% | $13.96M-5.1% | $11.68M+14.7% | $4.55M-35.6% | $11.39M+40.1% | ||
| $2.84M+153% | —— | $5.28M+199% | -$32.28M-238% | -$5.41M+28.7% | ||
| —— | $1.94M-78.2% | $14M+399% | $6.6M+43.1% | $0-100% | ||
| —— | -$5.99M— | -$2.12M+80.6% | -$13.32M-172% | -$610K-134% | ||
| —— | —— | -$22.1M-168% | $3.4M-37.6% | $8.12M-29.2% | ||
| —— | —— | $1M+7.1% | $148K— | $222K+33.7% | ||
| —— | -$2.88M— | -$380K-112% | $7.16M+515% | $6.81M— | ||
| —— | —— | -$27.4M-343% | $16.38M+255% | $2.31M-76.7% | ||
| -$2.37M— | —— | $2.05M— | —— | —— | ||
| $31.26M— | -$941K— | -$22.39M-3.8% | -$28.86M-261% | —— | ||
| $86.66M+111% | $82.41M-2.3% | $27.59M-56.8% | $98.2M+30.1% | $41.12M-49.2% | ||
| $9.09M-10.2% | $5.92M-13.2% | $5.36M-41.5% | $4.89M-72.8% | $10.12M-38.4% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$5.82M+34.4% | -$5.92M-17.7% | $605K+103% | $0+100% | -$8.87M+46.0% | ||
| $12.52M-0.5% | $12.47M-2.1% | $12.44M-1.9% | $12.39M-1.9% | $12.58M0.0% | ||
| —— | —— | $24K— | $100.06M+400% | $100.05M+400% | ||
| $60M+650% | $40M— | $46M+142% | $50M-28.6% | $8M-86.2% | ||
| $29.96M+101% | $4.74M-14.5% | $23.5M-6.4% | $6.23M-72.9% | $14.87M-18.9% | ||
| $157K-46.0% | $1.26M+23.9% | $9.23M+85.2% | $234K-41.8% | $291K+73.2% | ||
| -$42.72M+37.2% | -$48.99M+41.6% | -$44.2M-282% | -$90.45M-50.5% | -$68.05M-29.8% | ||
| -$1.19M-9.9% | —— | -$1.21M-124% | $13.36M— | -$1.08M+53.9% | ||
| $36.94M+200% | $27.92M— | -$17.22M-148% | $21.52M— | -$36.88M— | ||
| $2.99M-32.2% | $3.99M-13.8% | $4.82M-7.4% | —— | $4.4M+15.6% | ||
| $5.67M-69.0% | $5.87M-72.2% | $30.81M+86.9% | —— | $18.31M+154% | ||
| —— | —— | —— | $11.35M+331% | $120K— | ||
| -$739K-25.5% | $110K+139% | $294K-21.4% | $1.11M+239% | -$589K+66.3% | ||
| —— | —— | —— | $197K+10.1% | $181K-2.7% | ||
| $31.26M— | -$941K— | -$22.39M-3.8% | -$28.86M-261% | —— | ||
| —— | —— | -$22.1M-168% | $3.4M-37.6% | $8.12M-29.2% | ||
| —— | -$2.88M— | -$380K-112% | $7.16M+515% | $6.81M— | ||
| -$839K-8,490% | -$868K-1,947% | -$912K-305% | $183K— | $10K-98.4% | ||
| —— | —— | $6.79M— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | $4.62M— | $658K— | —— | ||
| —— | —— | —— | $1.82M+4.2% | $1.82M+4.2% | ||
| —— | —— | —— | $66M— | $38M— | ||
| -$2.37M— | —— | $2.05M— | —— | —— | ||
| $77.58M+150% | $76.49M-1.3% | $22.22M-59.4% | $93.31M+62.2% | $31M-52.0% | ||
| $77.58M+150% | $76.49M-1.3% | $22.22M-59.4% | $93.31M+62.2% | $31M-52.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Bio-Techne generate?
- Bio-Techne (TECH) generated $294.9M in operating cash flow over the trailing twelve months.
- What is Bio-Techne's free cash flow?
- After $25.3M of capital expenditures, Bio-Techne's free cash flow was $269.6M over the trailing twelve months, up 22.1% year over year.
- Where does Bio-Techne's cash flow data come from?
- Every line is extracted from Bio-Techne's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
